Cargando…

Enhanced cell killing in lewis lung carcinoma and a human pancreatic-carcinoma xenograft by the combination of cytotoxic drugs and misonidazole.

The "chemosensitizing" properties of the radiosensitizer misonidazole (MISO) were examined in 2 tumour systems, murine Lewis lung carcinoma and human pancreatic adenocarcinoma xenografted into immune-suppressed mice, using a soft-agar colony assay to measure tumour-cell survival. In mice b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stephens, T. C., Courtenay, V. D., Mills, J., Peacock, J. H., Rose, C. M., Spooner, D.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1981
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010637/ https://www.ncbi.nlm.nih.gov/pubmed/7236488

Ejemplares similares

The spectrum of chemosensitivity of two human pancreatic carcinoma xenografts.
por: Courtenay, V. D., et al.
Publicado: (1982)

Bleomycin and misonidazole cytotoxicity.
por: Korbelik, M., et al.
Publicado: (1985)

Split dose cytotoxic experiments with misonidazole.
por: Stratford, I. J.
Publicado: (1978)

Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain.
por: Hirst, D. G., et al.
Publicado: (1982)

Cytotoxic effect of misonidazole and cyclophosphamide on aerobic and hypoxic cells in a C3H mammary carcinoma in vivo.
por: Grau, C., et al.
Publicado: (1990)

Combination studies with misonidazole and a cis-platinum complex: cytotoxicity and radiosensitization in vitro.
por: Stratford, I. J., et al.
Publicado: (1980)

Misonidazole and MTDQ in combination: cytotoxic and radiosensitizing properties in hypoxic mammalian cells.
por: Astor, M., et al.
Publicado: (1979)

Enhancement of melphalan-induced tumour cell killing by misonidazole: an interaction of competing mechanisms.
por: Horsman, M. R., et al.
Publicado: (1984)

Repopulation of gamma-irradiated Lewis lung carcinoma by malignant cells and host macrophage progenitors.
por: Stephens, T. C., et al.
Publicado: (1978)

Enhanced cytotoxicity of antineoplastic agents following prolonged exposure to misonidazole.
por: Roizin-Towle, L. A., et al.
Publicado: (1981)

In vitro metabolism of misonidazole.
por: Josephy, P. D., et al.
Publicado: (1981)

Cytotoxicity of metronidazole (Flagyl) and misonidazole (Ro-07-0582): enhancement by lactate.
por: Mahood, J. S., et al.
Publicado: (1981)

Enhancement of nitrosourea cytotoxicity by misonidazole in vitro: correlation with carbamoylating potential.
por: Mulcahy, R. T., et al.
Publicado: (1984)

Distribution and tumour cytotoxicity of the radiosensitizer misonidazole (Ro-07-0582) in C57 mice.
por: Pedersen, J. E., et al.
Publicado: (1979)

In vivo combination of misonidazole and the chemotherapeutic agent CCNU.
por: Siemann, D. W.
Publicado: (1981)

Pancreatic Carcinoma: the Disease that Kills
por: Kabashi, Serbeze, et al.
Publicado: (2016)

A phase I study of misonidazole and pelvic irradiation in patients with carcinoma of cervix.
por: Thomas, G. M., et al.
Publicado: (1982)

Oxygen dependence for chemosensitization by misonidazole.
por: Roizin-Towle, L., et al.
Publicado: (1986)

Effect of misonidazole on radiation injury to mouse spinal cord.
por: Travis, E. L., et al.
Publicado: (1982)

Chemosensitization by misonidazole in CCNU-treated spheroids and tumours.
por: Durand, R. E., et al.
Publicado: (1987)

Hypoxic cells and in situ chemopotentiation of the nitrosoureas by misonidazole.
por: Wheeler, K. T., et al.
Publicado: (1984)

Lycopene in Combination With Sorafenib Additively Inhibits Tumor Metastasis in Mice Xenografted With Lewis Lung Carcinoma Cells
por: Chan, Ya-Ping, et al.
Publicado: (2022)

The penetration of misonidazole into a mature structural cartilage.
por: Langler, A. J., et al.
Publicado: (1982)

The quantitative response of human tumours to radiation and misonidazole.
por: Ash, D. V., et al.
Publicado: (1979)

A biochemical method for assessing the neurotoxic effects of misonidazole in the rat.
por: Rose, G. P., et al.
Publicado: (1980)

The role of dexamethasone in the modification of misonidazole pharmacokinetics.
por: Jones, D. H., et al.
Publicado: (1983)

Is tumour radiosensitization by misonidazole a general phenomenon?
por: Denekamp, J., et al.
Publicado: (1980)

Chemopotentiation of CCNU metabolites by misonidazole.
por: Mulcahy, R. T.
Publicado: (1985)

Microscopic distribution of misonidazole in mouse tissues.
por: Cobb, L. M., et al.
Publicado: (1989)

Factors influencing the chemosensitization of melphalan by misonidazole.
por: Randhawa, V. S., et al.
Publicado: (1985)

Distribution of misonidazole in human tumours and normal tissues.
por: Ash, D. V., et al.
Publicado: (1979)

The effects of melphalan and misonidazole on the vasculature of a murine sarcoma.
por: Murray, J. C., et al.
Publicado: (1987)

Effects of local hyperthermia on the pharmacokinetics of misonidazole in the anaesthetized mouse.
por: Honess, D. J., et al.
Publicado: (1980)

Oncogenic transformation in vitro by the hypoxic cell sensitizer misonidazole.
por: Miller, R. C., et al.
Publicado: (1978)

Phenytoin-induced changes in the pharmacokinetics of misonidazole in radiotherapy patients.
por: Moore, J. L., et al.
Publicado: (1981)

Quantitative cytochemical assessment of the neurotoxicity of misonidazole in the mouse.
por: Clarke, C., et al.
Publicado: (1982)

Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
por: Siemann, D. W.
Publicado: (1982)

Studies with bleomycin and misonidazole on aerated and hypoxic cells.
por: Roizin-Towle, L., et al.
Publicado: (1978)

Peripheral electrophysiological parameters in mice treated with misonidazole.
por: Von Burg, R., et al.
Publicado: (1979)

The penetration of misonidazole into spontaneous canine tumours.
por: White, R. A., et al.
Publicado: (1979)

Cannot write session to /tmp/vufind_sessions/sess_mdg49i9e7eouvji40f5tg0rejh